The reference multimedia journal in interventional cardiology

issue

Aug 19, 2022

Volume 18 Number 6

This issue includes the second part of the expert consensus by the European Bifurcation Club on implanting two stents with a procedural overview, consideration of technical issues and a look towards future coronary bifurcation lesion treatment. In Coronary Interventions: possible implementation of one-month dual antiplatelet therapy followed by aspirin depending on clinical presentation of patient – stable CAD, but not for ACS; an investigation of outcomes of STEMI patients with no stenting or deferred stenting compared to stented STEMI patients; 3-year results of the TALENT trial comparing the sirolimus-eluting ultrathin strut SUPRAFLEX stent with the XIENCE stent. In Interventions for Valvular Disease and Heart Failure, the failure of ARC high bleeding risk criteria to adequately cover TAVI patients; 12-month analysis of MITRA-FR trial comparing heart failure hospitalisation rates for patients treated by transcatheter mitral valve repair as opposed to guideline directed medical therapy...and more!

In this issue of EuroIntervention

Part 2 of the consensus document of the European Bifurcation Club; one-month DAPT after PCI depending on clinical presentation; deferred or no-stenting in patients with STEMI; ARC high bleeding risk criteria and TAVI; hospitalisation for heart failure in the MITRA-FR trial; and more

Capodanno D

free

EAPCI Column

EAPCI Presidential “criss-cross”

Barbato E, Dudek D

10.4244/EIJ-E-22-00028

free

Viewpoint

Low-dose fibrinolysis during primary percutaneous intervention for preventing no-reflow: stepping back to move forward?

Pelliccia F, Niccoli G

10.4244/EIJ-D-22-00250

free

Coronary interventions

Treatment of coronary bifurcation lesions, part II: implanting two stents. The 16th expert consensus document of the European Bifurcation Club

Lassen JF, Albiero R, Johnson T, Burzotta F, Lefèvre T, Iles TL, Pan M, Banning A, Chatzizisis Y, Ferenc M, Dzavik V, Milasinovic D, Darremont O, Hildick-Smith D, Louvard Y, Stankovic G

10.4244/EIJ-D-22-00166

free

Impact of one-month DAPT followed by aspirin monotherapy in patients undergoing percutaneous coronary intervention according to clinical presentation: a post hoc analysis of the randomised One-Month DAPT trial

Lee Y, Cho JY, Yun KH, Lee S, Hong S, Ahn C, Kim B, Ko Y, Choi D, Hong M, Jang Y, Kim J

10.4244/EIJ-D-22-00135

free

Editorial comment

One-month DAPT after acute coronary syndrome: too short or not too short?

Capranzano P

10.4244/EIJ-E-22-00022

free

Clinical outcomes of no stenting in patients with ST-segment elevation myocardial infarction undergoing deferred primary percutaneous coronary intervention

Madsen J, Kelbæk H, Nepper-Christensen L, Jacobsen M, Ahtarovski KA, Høfsten D, Holmvang L, Pedersen F, Tilsted H, Aarøe J, Jensen SE, Raungaard B, Terkelsen CJ, Køber L, Engstrøm T, Lønborg J

10.4244/EIJ-D-21-00950

free

Editorial comment

Defer-based non-stenting: a promising approach for STEMI

Jia H, He L

10.4244/EIJ-E-22-00023

free

Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial

de Winter R, Zaman A, Hara H, Gao C, Ono M, Garg S, Smits PC, Tonino P, Hofma S, Moreno R, Choudhury A, Petrov I, Cequier A, Colombo A, Kaul U, Onuma Y, Serruys PW

10.4244/EIJ-D-21-00766

free

Interventions for valvular disease and heart failure

Bleeding risk differences after TAVR according to the ARC-HBR criteria: insights from SCOPE 2

Garot P, Neylon A, Morice M, Tamburino C, Bleiziffer S, Thiele H, Scholtz S, Schramm R, Cockburn J, Cunnington M, Wolf A, Barbanti M, Tchétché D, Pagnotta P, Gilard M, Bedogni F, Van Belle E, Vasa-Nicotera M, Chieffo A, Bogaerts K, Hengstenberg C, Capodanno D

10.4244/EIJ-D-21-01048

free

Editorial comment

ARC-HBR criteria and TAVR: not all high bleeding risk patients look alike

Krucoff M, Cao D, Mehran R

10.4244/EIJ-E-22-00024

free

Delayed hospitalisation for heart failure after transcatheter repair or medical treatment for secondary mitral regurgitation: a landmark analysis of the MITRA-FR trial

Leurent G, Auffret V, Donal E, Corbineau H, Grinberg D, Bonnet G, Leroux P, Guérin P, Wautot F, Lefèvre T, Messika-Zeitoun D, Iung B, Armoiry X, Trochu J, Boutitie F, Obadia J

10.4244/EIJ-D-21-00846

free

Letter to the editor

Letter: Caffeine and fractional flow reserve overestimation: a word of caution

Siig C, Ahmad M

10.4244/EIJ-D-21-01009L

free

Reply: Caffeine and fractional flow reserve overestimation: a word of caution

Matsumoto H

10.4244/EIJ-D-21-01009R

free